ClinConnect ClinConnect Logo
Search / Trial NCT02609542

Memorisation of Phonologic Information Among Children With Oral Language Developement Disorder

Launched by LILLE CATHOLIC UNIVERSITY · Nov 17, 2015

Trial Information

Current as of May 27, 2025

Recruiting

Keywords

Oral Language Stol Memory Eye Tracking

ClinConnect Summary

This clinical trial is studying children with a specific speech and language development disorder, known as STOL (Specific Troubles of Oral Language). Researchers want to understand how well these children can remember and learn spoken words compared to children who develop language skills normally. The study will focus on children between 3 and 8 years old, particularly looking at those whose language challenges improve as they grow. The goal is to see if children with reduced STOL symptoms by ages 4 to 7 perform better in remembering words than those whose symptoms continue past age 6.

To participate, children must be between 3 years 9 months and 7 years 9 months, have normal hearing and vision, and meet certain intelligence testing criteria. Children with STOL must have a diagnosis confirmed by a medical team, while control children should not have had any speech therapy. Parents or legal guardians will need to provide consent for their child to take part. If eligible, participants will engage in activities that assess their ability to memorize and understand spoken language. This trial aims to provide valuable insights into language development and may help improve support for children with language challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria for STOL patients:
  • Child aged between 45 and 95 months at inclusion
  • A score \> or equal to 5 percentile on the non verbal intelligence test (PM47)
  • Patient diagnosed with STOL by the neuropediatric medical team
  • Coverage of the social insurance
  • Consent form signed by the parents or the legal representative of the child
  • Normal or corrected sight
  • Normal hearing
  • Inclusion Criteria for control patients:
  • Child aged between 45 and 95 months on the day of inclusion
  • A score \> or equal to 5 percentile on the non verbal intelligence test (PM47)
  • Child who did not receive any speech therapy
  • Coverage of the social insurance
  • Consent form signed by the parents or the legal representative of the child
  • Normal or corrected sight
  • Normal hearing
  • Exclusion Criteria for STOL patients:
  • Mother language other than French
  • Score \< to 5 percentile on the non verbal intelligence test (PM47)
  • Child with pervasive developmental disorder
  • Exclusion Criteria for control patients:
  • Mother language other than French
  • Score \< to 5 percentile on the non verbal intelligence test (PM47)
  • Child who received speech therapy

About Lille Catholic University

Lille Catholic University, a prominent academic institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates expertise from various fields to foster the development of cutting-edge medical solutions. Its commitment to ethical standards and patient-centered approaches ensures that clinical trials conducted under its auspices are rigorous, scientifically sound, and aligned with the highest standards of care. By leveraging its extensive network of researchers, healthcare professionals, and resources, Lille Catholic University plays a vital role in contributing to the enhancement of medical knowledge and the improvement of patient outcomes.

Locations

Lille, Nord Pas De Calais, France

Patients applied

0 patients applied

Trial Officials

Delphine Fleurion, Psychologist

Principal Investigator

Groupement des Hôpitaux de l'Institut Catholique de Lille

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials